Optas LLC trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,872 shares of the company’s stock after selling 126 shares during the period. Optas LLC’s holdings in Procter & Gamble were worth $936,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of PG. Benjamin Edwards Inc. lifted its stake in Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after purchasing an additional 199,258 shares during the last quarter. Capital Investment Advisory Services LLC lifted its stake in Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock valued at $6,426,000 after purchasing an additional 4,562 shares during the last quarter. World Investment Advisors lifted its stake in Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock valued at $8,677,000 after purchasing an additional 2,886 shares during the last quarter. Concurrent Investment Advisors LLC lifted its stake in Procter & Gamble by 26.4% in the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock valued at $20,451,000 after purchasing an additional 25,059 shares during the last quarter. Finally, Kelly Financial Services LLC raised its holdings in Procter & Gamble by 8.7% in the 1st quarter. Kelly Financial Services LLC now owns 1,727 shares of the company’s stock valued at $294,000 after acquiring an additional 138 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares of the company’s stock, valued at $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last three months. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble Stock Down 1.2%
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm earned $1.40 earnings per share. The business’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Wall Street Analyst Weigh In
Several research firms have weighed in on PG. Berenberg Bank increased their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. BNP Paribas reissued an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Finally, Evercore ISI reissued an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $172.58.
Get Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- How to Use the MarketBeat Stock Screener
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- The 3 Best Fintech Stocks to Buy Now
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.